InsiderDirector

David V Goeddel Insider Trading Activity

Every SEC Form 4 transaction reported by David V Goeddel, sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Is David V Goeddel buying or selling?

David V Goeddel reported 62 open-market buys ($159.9M) and 0 sells ($0) across 62 Form 4 filings at 3 companies — a net buying position of $159.9M.

Source: SEC EDGAR Form 4

Key Statistics (as of Mar 8, 2025)

Total Form 4 filings
62
SEC EDGAR
Companies
3
Buys (62)
$159.9M
Sells (0)
$0

Insider sentiment

Net buying

Net insider flow of $159.9M in net buying, filed between Apr 10, 2019 – Mar 8, 2025.

Companies David V Goeddel files for

#CompanyForm 4 filings
1NGMNGM BIOPHARMACEUTICALS INC54
2TNYATenaya Therapeutics, Inc.7
3RAPTRAPT Therapeutics, Inc.1

Recent David V Goeddel transactions

DateTickerRoleTypeSharesValue
Mar 8, 2025TNYADirector, 10% OwnerPurchase35.7M$25.0M
Feb 14, 2024TNYADirector, 10% OwnerPurchase2.2M$10.0M
Nov 17, 2023NGMDirector, 10% OwnerPurchase26.8K$18.3K
Mar 14, 2023TNYADirector, 10% OwnerPurchase6.8K$17.6K
Feb 10, 2023TNYADirector, 10% OwnerPurchase1.5M$3.9M
Feb 1, 2023NGMDirector, 10% OwnerPurchase184.3K$921.1K
Jan 23, 2023TNYADirector, 10% OwnerPurchase69.7K$174.2K
Jan 23, 2023NGMDirector, 10% OwnerPurchase38.1K$190.6K
Jan 19, 2023TNYADirector, 10% OwnerPurchase185.2K$464.8K
Jan 17, 2023NGMDirector, 10% OwnerPurchase5.4K$26.6K
Jan 12, 2023NGMDirector, 10% OwnerPurchase309.1K$1.5M
Dec 14, 2022NGMDirector, 10% OwnerPurchase300$1.5K
Nov 23, 2022NGMDirector, 10% OwnerPurchase40.3K$201.6K
Nov 23, 2022TNYADirector, 10% OwnerPurchase9.6M$25.0M
Nov 7, 2022NGMDirector, 10% OwnerPurchase139.1K$684.4K
Oct 31, 2022NGMDirector, 10% OwnerPurchase76.9K$373.6K
Oct 27, 2022NGMDirector, 10% OwnerPurchase123.8K$595.4K
Oct 19, 2022NGMDirector, 10% OwnerPurchase130.0K$462.4K
Jun 13, 2022NGMDirector, 10% OwnerPurchase984.2K$13.3M
Jun 6, 2022NGMDirector, 10% OwnerPurchase34.2K$445.7K
Jun 2, 2022NGMDirector, 10% OwnerPurchase153.8K$2.1M
May 31, 2022NGMDirector, 10% OwnerPurchase22.9K$309.0K
May 26, 2022NGMDirector, 10% OwnerPurchase61.1K$819.9K
May 23, 2022NGMDirector, 10% OwnerPurchase39.7K$530.5K
May 19, 2022NGMDirector, 10% OwnerPurchase151.7K$2.0M

Showing the 25 most recent filings of 62. Screen every filing.

David V Goeddel insider trading FAQ

Is David V Goeddel buying or selling?

Across 62 SEC Form 4 filings, David V Goeddel reported 62 open-market purchases totaling $159.9M and 0 sales totaling $0 — a net buying position of $159.9M.

Which companies does David V Goeddel file Form 4s for?

David V Goeddel has reported insider transactions at 3 companies, most often NGM BIOPHARMACEUTICALS INC (NGM), Tenaya Therapeutics, Inc. (TNYA), RAPT Therapeutics, Inc. (RAPT).

How far back does David V Goeddel's filing history go?

Trabud holds David V Goeddel's SEC Form 4 filings from Apr 10, 2019 – Mar 8, 2025, sourced directly from SEC EDGAR.

Where does Trabud get David V Goeddel's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track David V Goeddel and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener